MabThera 500 (Rituximab Vials) 500mg/50ml

MabThera 500 (Rituximab) is a monoclonal antibody infusion used for immune-related conditions. This 500mg/50ml vial supports treatment of autoimmune disorders and certain cancers. Store at ambient temperature and consult healthcare guidance before use.

Strength

500mg/50ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Roche

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MabThera 500 (Rituximab) is commonly used to manage autoimmune disorders like rheumatoid arthritis and vasculitis. It is also prescribed for certain blood cancers, including non-Hodgkin lymphoma and chronic lymphocytic leukemia. Patients often ask, 'what is Rituximab used for' to understand its broad therapeutic role in immune modulation and oncology.

Side Effects

Rituximab works by targeting CD20-positive B-cells, helping reduce inflammation and abnormal cell growth. Users may notice gradual symptom improvement over time with regular infusions. Effects vary by condition and individual response.

Precautions & Warnings

Handle MabThera 500 with care, avoiding contamination and improper storage. Keep vials at ambient temperature and protect from light. Always follow healthcare provider instructions for preparation and administration to minimize risks.

Avoid Interactions

Rituximab may interact with immunosuppressants, vaccines, and certain chemotherapy drugs. Alcohol and other medications should be discussed with a healthcare professional before starting treatment. Monitor for unexpected reactions during and after infusions.

Frequently Asked Questions

MabThera 500 (Rituximab) is used to treat autoimmune disorders like rheumatoid arthritis and certain blood cancers such as non-Hodgkin lymphoma.

MabThera 500 is given as an intravenous infusion under medical supervision. Dosage and frequency depend on the condition being treated.

Common effects may include infusion reactions, fatigue, or flu-like symptoms. Severe reactions require immediate medical attention.

MabThera 500 requires a prescription and should be obtained through licensed pharmacies or healthcare providers.

Store MabThera 500 vials at ambient temperature, away from light and moisture. Do not freeze or refrigerate unless specified.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.